Syndax Pharmaceuticals Inc (37) | Human Resources (16)
Browse by Subcategory
Recent Contracts
-
Employment Agreement, dated June 8, 2022, by and between the Company and Keith A. Goldan
(Filed With SEC on June 13, 2022)
-
Non-employee Director Compensation Policy, as amended, dated as of February 2, 2022
(Filed With SEC on March 1, 2022)
-
Form of Deferred Settlement Stock Unit Agreement under 2015 Omnibus Incentive Plan
(Filed With SEC on March 12, 2021)
-
Executive Employment Agreement by and between the Company and Anjali Ganguli, Ph.D., dated as of September 30, 2021
(Filed With SEC on May 9, 2022)
-
Executive Employment Agreement by and between the Company and Catherine Madigan, M.D., dated as of March 1, 2022
(Filed With SEC on May 9, 2022)
-
Amended and Restated Executive Employment Agreement by and between the Company and Briggs W. Morrison, M.D., dated as of February 2, 2022
(Filed With SEC on March 1, 2022)
-
Amended and Restated Executive Employment Agreement by and between the Company and Michael A. Metzger, dated as of February 2, 2022
(Filed With SEC on March 1, 2022)
-
Amended and Restated Employment Agreement, dated February 2, 2022, by and between the Company and Briggs W. Morrison, M.D
(Filed With SEC on February 3, 2022)
-
Amended and Restated Employment Agreement, dated February 2, 2022, by and between the Company and Michael A. Metzger
(Filed With SEC on February 3, 2022)
-
Executive Employment Agreement by and between the Company and Daphne Karydas, dated as of July 6, 2020
(Filed With SEC on November 5, 2020)
-
Form of Stock Unit Agreement under 2015 Omnibus Incentive Plan
(Filed With SEC on August 6, 2020)
-
Non-employee Director Compensation Policy, as amended, February 12, 2020
(Filed With SEC on May 7, 2020)
-
Amended and Restated Executive Employment Agreement by and between the Company and Briggs W. Morrison, M.D., dated as of April 27, 2020
(Filed With SEC on May 7, 2020)
-
Amended and Restated Executive Employment Agreement by and between the Company and Michael A. Metzger, dated as of April 27, 2020
(Filed With SEC on May 7, 2020)
-
Amended and Restated Executive Employment Agreement by and between the Company and Michael L. Meyers, M.D., Ph.D., dated as of April 27, 2020
(Filed With SEC on May 7, 2020)
-
Amended and Restated Executive Employment Agreement by and between the Company and Richard P. Shea, dated as of April 27, 2020
(Filed With SEC on May 7, 2020)